ライフサイエンスコーパス: merozoite surface protein 1

1 ed from the circumsporozoite protein and the merozoite surface protein 1.

2 The anti-merozoite surface protein-1 19-kDa IgG (anti-MSP119KD) I

3 had higher subsequent levels of antibody to merozoite surface protein-1(19-kDa) (a marker of blood-s

4 ontaining the C terminus of Plasmodium vivax merozoite surface protein 1 and two T-helper epitopes of

5 mediated predominately via C1q fixation, and merozoite surface proteins 1 and 2 were identified as ma

6 zoite protein, sporozoite surface protein 2, merozoite surface protein 1, and 25-kDa sexual-stage ant

7 ntaining T-cell epitopes from LSA-1 and from merozoite surface protein-1, and a tri-epitope MAP (T3-C

8 Several functional proteins including merozoite surface protein 1 are anchored to the cell sur

9 s found that antibodies to 5 proteins of the Merozoite Surface Protein 1 complex were differentially

10 ge antigen-1, apical membrane antigen-1, and merozoite surface protein-1 do not to predict protection

11 of the system by targeting the P. falciparum merozoite surface protein 1 gene (msp1), which has previ

12 Using a newly developed Plasmodium vivax merozoite surface protein 1 gene (Pvmsp1) heteroduplex t

13 at a highly variable region of the P. vivax merozoite surface protein 1 gene revealed impressive div

14 ant protein subunits of the Plasmodium vivax merozoite surface protein 1 have been shown to bind to r

15 ral immune responses to the 19-kDa domain of merozoite surface protein 1 in individuals from an area

16 Merozoite surface protein 1 is a candidate for blood-sta

17 se and erythrocyte (spectrins) and parasite (merozoite surface protein 1) markers.

18 The 19-kDa subunit of P. falciparum merozoite surface protein 1 (MSP-1(19)), a major blood s

19 valence, fine specificity, and 19-kilodalton merozoite surface protein 1 (MSP-1(19))-specific erythro

20 The 42-kDa fragment of the merozoite surface protein 1 (MSP-1(42)) is a leading can

21 processed fragment of Plasmodium falciparum merozoite surface protein 1 (MSP-1(42)) is a prime candi

22 inal processed fragment of the P. falciparum merozoite surface protein 1 (MSP-1(42)) using the most f

23 g 1 (AMA-1), the 42-kDa C-terminal region of merozoite surface protein 1 (MSP-1(42)), a B epitope of

24 The Plasmodium vivax merozoite surface protein 1 (MSP-1) 42-kDa fragment (PvM

25 block 2 region of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) are associated with

26 of the 96-residue C-terminal fragment of the merozoite surface protein 1 (MSP-1) from Plasmodium falc

27 lypeptide based on the Plasmodium falciparum merozoite surface protein 1 (MSP-1) has been evaluated i

28 Merozoite surface protein 1 (MSP-1) is a precursor to ma

29 The major merozoite surface protein 1 (MSP-1) is currently a leadi

30 ythrocyte binding antigen 175 (EBA-175), and merozoite surface protein 1 (MSP-1) were compared in 243

31 igens, apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP-1).

32 nal 19-kDa fragment of Plasmodium falciparum merozoite surface protein-1 (MSP-1(19)) is a target of p

33 cell sensitization to Plasmodium falciparum merozoite surface protein-1 (MSP-1) at birth correlates

34 duced by the carboxyl-terminal region of the merozoite surface protein-1 (MSP-1) from the rodent mala

35 blood T and B cell immunity to P. falciparum merozoite surface protein-1 (MSP-1) in infants born in a

36 Merozoite surface protein-1 (MSP-1) of Plasmodium falcip

37 circumsporozoite protein (CSP) and P. yoelii merozoite surface protein-1 (MSP-1) showed encouraging r

38 n the C terminus (PyC2) of Plasmodium yoelii merozoite surface protein-1 (MSP-1), a leading vaccine c

39 didates SE36 and 42-kDa region of the 3D7 Pf merozoite surface protein-1 (MSP-1), and tetanus toxoid

40 maternal cytokine and antibody responses to merozoite surface protein-1 (MSP-1), ribosomal phosphopr

41 cting with a major invasion-related protein, merozoite surface protein-1 (MSP-1).

42 The C-terminal 19-kDa domain of merozoite surface protein 1 (MSP1(1)(9)) is the target o

43 igen 175 (EBA-175), and the 19-kDa region of merozoite surface protein 1 (MSP1(19)).

44 ow that the 33-kDa fragment of P. falciparum merozoite surface protein 1 (MSP1(33)), an abundant prot

45 eracts with the 42-kDa processing product of merozoite surface protein 1 (MSP1(42)) through its 19-kD

46 C-terminal portion of Plasmodium falciparum merozoite surface protein 1 (MSP1(42)).

47 lood-stage malaria vaccine targets, that is, merozoite surface protein 1 (MSP1) and apical membrane A

48 A1), merozoite surface antigen 2 (MSA2), and merozoite surface protein 1 (MSP1) are asexual-stage pro

49 the block 2 region of Plasmodium falciparum merozoite surface protein 1 (MSP1) are associated with a

50 For comparison, plasma IgG levels to two merozoite surface protein 1 (MSP1) constructs, MSP1-19 a

51 , epidermal growth factor-like region of the merozoite surface protein 1 (MSP1) has been used as a va

52 or-transgenic mouse recognizing a peptide of merozoite surface protein 1 (MSP1) injected into BALB/c

53 Merozoite surface protein 1 (MSP1) is a target for malar

54 42-kDa fragment from the C terminus of major merozoite surface protein 1 (MSP1) is among the leading

55 To date, merozoite surface protein 1 (MSP1) is regarded as the le

56 The merozoite surface protein 1 (Msp1) is the most-abundant

57 Vaccination with native full-length merozoite surface protein 1 (MSP1) or with recombinant C

58 oite surface comprises three proteins called merozoite surface protein 1 (MSP1), MSP6 and MSP7.

59 block 2 region of the Plasmodium falciparum merozoite surface protein 1 (MSP1), to which allele-spec

60 of a vaccine based on Plasmodium falciparum merozoite surface protein 1 (MSP1), we evaluated the eff

61 dant protein on the surface of merozoites is merozoite surface protein 1 (MSP1), which consists of fo

62 induced by vaccination in animal models with merozoite surface protein 1 (MSP1), which makes this pro

63 ating antibodies to the carboxyl terminus of merozoite surface protein 1 (MSP1).

64 inding the C-terminal processing products of merozoite surface protein 1 (MSP1).

65 the carboxyl-terminal 19-kDa segment of the merozoite surface protein 1 (MSP1-19), the ring-infected

66 teers vaccinated with a portion of the major merozoite surface protein-1 (MSP1) of Plasmodium falcipa

67 Merozoite surface protein-1 (MSP1), a prime malaria vacc

68 ules anchored to the parasite surface is the merozoite surface protein-1 (MSP1).

69 clone (apical membrane antigen 1, AMA1-3D7; merozoite surface protein 1, MSP1-3D7; 175 kDa erythrocy

70 fusion of the C-terminal 19-kDa fragment of merozoite surface protein 1 (MSP119) to P. falciparum MS

71 -terminal 19-kDa region of Plasmodium yoelii merozoite surface protein 1 (MSP119), a major target of

72 pecimens from Mozambique: 19-kDa fragment of merozoite surface protein 1 (MSP119), erythrocyte bindin

73 C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP142) and the risk of (re

74 minal 19-kDa domain of Plasmodium falciparum merozoite surface protein 1 (PfMSP119) is an established

75 ens, apical merozoite antigen 1 (PkAMA1) and merozoite surface protein 1 (PkMSP1p42), as well as reco

76 sponse and demonstrated improved efficacy of merozoite surface protein-1 protein vaccines against a P

77 orm and C and N termini of Plasmodium yoelii merozoite surface protein 1 provided partial protection

78 and the 19-kDa C-terminal region of P. vivax merozoite surface protein 1 (PvMSP1(19)), would have a d

79 didates, the 19 kDa fragment of the P. vivax Merozoite Surface Protein 1 (PvMSP119) is one of the mos

80 Similar to Plasmodium falciparum merozoite surface protein 1, pypAg-2 contains two C-term

81 A recombinant malaria vaccine antigen, the merozoite surface protein 1 (rMSP1), was conjugated to I

82 in 2), liver (liver stage antigen 1), blood (merozoite surface protein 1, serine repeat antigen, and

83 d ability to present the P chabaudi antigen, merozoite surface protein-1, to specific T-cell receptor

84 king assay used to genotype Plasmodium vivax merozoite surface protein 1 was adapted to a capillary e

85 eted Plasmodium yoelii-derived 19-kilodalton merozoite surface protein 1 (yMSP1(19)) has been shown t

86 visiae-expressed 19-kDa C-terminal region of merozoite surface protein 1 (yMSP1(19)) of the murine ma